Skip to main content

Table 3 Frequency analysis of participant allocation to each treatment group

From: The effectiveness of ENAR®for the treatment of chronic neck pain in Australian adults: a preliminary single-blind, randomised controlled trial

Treatment Groups

  

Frequency

Percent

Valid Percent

Cumulative Percent

Valid

ENAR

9

37.5

37.5

37.5

 

TENS

7

29.2

29.2

66.7

 

SHAM

8

33.3

33.3

100.0

 

Total

24

100.0

100.0